News

Industry News

Overview and Preparation of Icatibant acetate23 2026-06

Overview and Preparation of Icatibant acetate

Icatibant acetate is a synthetic decapeptide approved by the FDA in 2011 for the acute treatment of hereditary angioedema (HAE) in adults. Acting as a potent, selective competitive antagonist of the bradykinin B2 receptor, it counteracts bradykinin‑induced vasodilation and vascular permeability, thereby alleviating swelling, inflammation, and pain during HAE attacks. The peptide incorporates five non‑proteinogenic amino acids, which confer high stability and receptor affinity.
In-depth article: N-methylation, α -methylation, D-amino acids, unnatural amino acids for polypeptide09 2026-06

In-depth article: N-methylation, α -methylation, D-amino acids, unnatural amino acids for polypeptide

Natural peptides are excellent "molecular keys" - they have high affinity, good selectivity and low toxicity. However, they inherently have three major weaknesses: they are easily chopped up by proteases, have difficulty penetrating cell membranes, and stay in the body for too short a time. Over the past three decades, pharmaceutical professionals have systematically addressed these shortcomings with a "toolbox of special amino acids". This article uses plain language and a large number of charts to guide CMC R&D peers to disassemble and understand this toolbox from principle to implementation.
Why Is Pralatrexate Important in Modern Cancer Treatment?02 2026-06

Why Is Pralatrexate Important in Modern Cancer Treatment?

Pralatrexate is a specialized antifolate chemotherapy drug primarily used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Since its introduction, it has become an important therapeutic option for patients who have limited treatment alternatives.
How is MAAA-1162a synthesized?29 2026-05

How is MAAA-1162a synthesized?

MAAA-1162a (Deruxtecan, MC-GGFG-DXd) is a drug-linker complex of detrastuzumab (DS-8201a), formed by DXd (MAAA-1181a, payload) and maleimide-tetrapeptide linker (MC-GGFG) through chemical coupling.
The synthesis of doxercalciferol28 2026-05

The synthesis of doxercalciferol

The synthesis of doxercalciferol (1α-hydroxyvitamin D₂) usually starts with vitamin D₂ (ergocalciferol) as the starting material, and introduces the 1α-hydroxyl group through selective protection, oxidation, and photoisomerization
With GLP-1 Regulatory Bars Set at a 0.1% Identification Threshold, Is Your Sucrose Octasulfate-Aluminum Complex (Orforglipron Impurity 18) Reference Standard Robust Enough for Forced Degradation and ANDA Filing?28 2026-05

With GLP-1 Regulatory Bars Set at a 0.1% Identification Threshold, Is Your Sucrose Octasulfate-Aluminum Complex (Orforglipron Impurity 18) Reference Standard Robust Enough for Forced Degradation and ANDA Filing?

This article examines why your reference standard for Sucrose Octasulfate-Aluminum Complex (Orforglipron Impurity 18) must meet the highest standards of purity, characterization, and regulatory compliance, and explores how Cosper Pharma Tech Co., Ltd. can support your impurity profiling and ANDA filing journey.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
RejectAccept